---
title: "Medtronic’s Symplicity Spyral system approved for use in China"
date: "2024-05-07T08:42:08.000Z"
publishedDate: "7 mai 2024"
summary: "Medtronic has announced it received approval from the National Medical Products Administration (NMPA) in China for its Symplicity Spyral renal denervation system. Symplicity Spyral is the first renal denervation system in China to receive NMPA approval."
importance: ""
sourceUrl: "https://cardiovascularnews.com/medtronics-symplicity-spyral-system-approved-for-use-in-china/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-05-07-medtronics-symplicity-spyral-system-approved-for-use-in-china"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/03/RDN-spyral-pic-crop.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/medtronics-symplicity-spyral-system-approved-for-use-in-china/"
---

![Medtronic’s Symplicity Spyral system approved for use in China](https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/03/RDN-spyral-pic-crop.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/medtronics-symplicity-spyral-system-approved-for-use-in-china/*

## L’essentiel

Medtronic has announced it received approval from the National Medical Products Administration (NMPA) in China for its Symplicity Spyral renal denervation system. Symplicity Spyral is the first renal denervation system in China to receive NMPA approval.

## Lien source

https://cardiovascularnews.com/medtronics-symplicity-spyral-system-approved-for-use-in-china/
